SCHEMBL59933

SCHEMBL59933

CCOC(=O)CNC(=O)CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 6/20 0.79
EPHA2 P29317 5/20 0.79
VDR P11473 4/20 0.79
HIF1A Q16665 3/20 0.72
CYP2C9 P11712 2/20 0.72
USP2 O75604 2/20 0.72
CYP3A4 P08684 2/20 0.71
CYP2C19 P33261 1/20 0.71
ABCC4 O15439 1/20 0.69
CASP7 P55210 3/20 0.67
TP53 P04637 2/20 0.67
MAPK1 P28482 2/20 0.67
HSD17B10 Q99714 2/20 0.67
BLM P54132 2/20 0.67
TDP1 Q9NUW8 2/20 0.67
MDM4 O15151 1/20 0.67
MAPT P10636 1/20 0.67
HSPD1 P10809 1/20 0.67
TSHR P16473 1/20 0.67
PTPN2 P17706 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13648593 0.90 GPBAR1 (0.81) GPBAR1EPHA2VDRHIF1ACYP2C9
SCHEMBL5442890 0.90 GPBAR1 (0.81) GPBAR1EPHA2VDRHIF1ACYP2C9
SCHEMBL19565489 0.90 GPBAR1 (0.81) GPBAR1EPHA2VDRHIF1ACYP2C9
SCHEMBL5442887 0.90 GPBAR1 (0.81) GPBAR1EPHA2VDRHIF1ACYP2C9
Lithoglycocholate SCHEMBL24001379 0.88 GPBAR1 (1.00) GPBAR1EPHA2VDRHIF1ACYP2C9
Lithoglycocholate SCHEMBL5062940 0.88 GPBAR1 (1.00) GPBAR1EPHA2VDRHIF1ACYP2C9
Lithoglycocholate SCHEMBL736797 0.88 GPBAR1 (1.00) GPBAR1EPHA2VDRHIF1ACYP2C9
Lithoglycocholate SCHEMBL13851599 0.88 GPBAR1 (1.00) GPBAR1EPHA2VDRHIF1ACYP2C9
SCHEMBL19104667 0.88 GPBAR1 (0.86) GPBAR1EPHA2VDRHIF1ACYP2C9
Lithoglycocholate SCHEMBL27044630 0.88 GPBAR1 (1.00) GPBAR1EPHA2VDRHIF1ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 435 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200246449-A1 INTRAVENOUS IMMUNOGLOBULIN COMPOSITIONS SPECIFIC FOR RESPIRATORY SYNCYTIAL VIRUS AND METHODS OF MAKING AND USING THE SAME NANOBIO CORPORATION (US) 2020-08-06 US claimed
WO-2018204669-A1 INTRAVENOUS IMMUNOGLOBULIN COMPOSITIONS SPECIFIC FOR RESPIRATORY SYNCYTIAL VIRUS AND METHODS OF MAKING AND USING THE SAME NANOBIO CORPORATION (US) 2018-11-08 WO claimed
EP-2437879-B1 MULTI-PHASE MICROPARTICLES AND METHOD OF MANUFACTURING MULTI-PHASE MICROPARTICLES UNIV NANYANG TECH (SG) 2017-07-26 EP claimed
US-9616031-B2 Method for encapsulating particles NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2017-04-11 US claimed
EP-2642984-B1 METHOD FOR ENCAPSULATING PARTICLES UNIV NANYANG TECH (SG) 2017-01-11 EP claimed
US-9381163-B2 Floating capsules encapsulating particles loaded with one or more drugs NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2016-07-05 US claimed
US-20150164815-A1 FLOATING CAPSULES ENCAPSULATING PARTICLES LOADED WITH ONE OR MORE DRUGS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2015-06-18 US claimed
EP-2729169-A1 HUMAN RESPIRATORY SYNCYTIAL VIRUS VACCINE Nanobio Corporation (US) 2014-05-14 EP claimed
WO-2014027956-A1 FLOATING CAPSULES ENCAPSULATING PARTICLES LOADED WITH ONE OR MORE DRUGS NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2014-02-20 WO claimed
US-20130302429-A1 METHOD FOR ENCAPSULATING PARTICLES NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2013-11-14 US claimed
WO-2009129470-A2 METHODS FOR TREATING HERPES VIRUS INFECTIONS NANOBIO CORPORATION (US) 2009-10-22 WO claimed
WO-2009120151-A1 MEMBRANE MADE OF A NANOSTRUCTURED MATERIAL NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2009-10-01 WO claimed
WO-2009011658-A1 HOLLOW POROUS MICROSPHERES NANYANG TECHNOLOGICAL UNIVERSITY (SG) 2009-01-22 WO claimed
US-20080050842-A1 METHOD OF VISUALIZATION AND QUANITIFICATION OF BIOPOLYMER MOLECULES IMMOBILIZED ON SOLID SUPPORT GOLOVLEV VALERI V 2008-02-28 US claimed
EP-1608392-A4 PAPANICOLAU STAINING PROCESS CYTYC CORP (US) 2007-09-05 EP claimed
US-7186522-B2 Using detergents to reduce artifacts during staining of biological samples; medical diagnostics and cervical cancer CYTYC CORPORATION (US) 2007-03-06 US claimed
US-20070003998-A1 Papanicolau staining process THIRD WAVE TECHNOLOGIES, INC. 2007-01-04 US claimed
EP-1608392-A2 PAPANICOLAU STAINING PROCESS Cytyc Corporation (US) 2005-12-28 EP claimed
WO-2004086945-A2 PAPANICOLAU STAINING PROCESS CYTYC CORPORATION (US) 2004-10-14 WO claimed
US-20040191854-A1 Papanicolau staining process CYTYC CORPORATION 2004-09-30 US claimed